Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “HEPATITIS”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT01180790
What this trial is testing

Safety, Tolerability, and Antiviral Activity of ACH-0141625 or Placebo in Combination With Peginterferon and Ribavirin in Hepatitis C Virus (HCV) Positive Participants

Who this might be right for
Hepatitis C
Alexion Pharmaceuticals, Inc. 122
Post-approval studies (Phase 4)Study completedNCT00353418
What this trial is testing

PEGASYS (Peginterferon Alfa-2a (40KD)) Plus COPEGUS (Ribavirin) in Patients With Chronic Hepatitis C (CHC) Genotype 1 and Human Immunodeficiency Virus-1 (HIV-1) Co-infection

Who this might be right for
Hepatitis C, Chronic
Hoffmann-La Roche 415
Testing effectiveness (Phase 2)Study completedNCT01816490
What this trial is testing

THISTLE - The HIV-HCV Silibinin Trial

Who this might be right for
HIVHepatitis C
University of Zurich 20
Not applicableStudy completedNCT01525810
What this trial is testing

Three-year Follow-up Study of Subjects Who Participated in a Previous Lambda (BMS-914143) Chronic Hepatitis C Clinical Trial

Who this might be right for
Hepatitis C
Bristol-Myers Squibb 218
Testing effectiveness (Phase 2)Study completedNCT01026610
What this trial is testing

Safety and Efficacy Study of LB80380 in the Treatment-naive Patients of Chronic Hepatitis B

Who this might be right for
Chronic Hepatitis B
LG Life Sciences 115
Large-scale testing (Phase 3)Study completedNCT03186313
What this trial is testing

Evaluate the Safety and Efficacy of the Combined Single Dose of Dactavira Plus Or Dactavira in Egyptian Adults With Chronic Genotype 4 HCV Infection

Who this might be right for
Hepatitis C
Egyptian Liver Hospital 72
Not applicableStudy completedNCT00916474
What this trial is testing

Virology Follow up Study in Subjects Previously Treated With Telaprevir

Who this might be right for
Hepatitis C
Vertex Pharmaceuticals Incorporated 408
Not applicableStudy completedNCT02597790
What this trial is testing

A Prospective, Longitudinal Study of Endothelial Function in HIV/HCV Coinfected Subjects

Who this might be right for
HIVHepatitis C
University of California, Los Angeles 87
Not applicableStudy completedNCT06606197
What this trial is testing

Hepatitis C Prevalence in Men Who Have Sex With Men

Who this might be right for
Hepatitis C
Consorci Sanitari de l'Alt Penedès i Garraf 454
Not applicableNot Yet RecruitingNCT07338851
What this trial is testing

The Five-year Antibody Persistence After Immunization With IPV, MMR and HepA-L Vaccines

Who this might be right for
PolioMeaslesRubella+2 more
China National Biotec Group Company Limited 600
Testing effectiveness (Phase 2)Study completedNCT01987453
What this trial is testing

Ledipasvir/Sofosbuvir Fixed-Dose Combination ± Ribavirin in Participants With Chronic Genotype 1 HCV Who Participated in a Prior Gilead-Sponsored HCV Treatment Study

Who this might be right for
HCV Infection
Gilead Sciences 100
Not applicableUnknownNCT00701272
What this trial is testing

FGL2/Fibroleukin and Hepatitis C Virus Recurrence Post Liver Transplantation

Who this might be right for
Liver TransplantationHepatitis C
University Health Network, Toronto 70
Testing effectiveness (Phase 2)Study completedNCT02430194
What this trial is testing

Lonafarnib Boosted With Ritonavir With and Without Peginterferon Alfa-2a (PEG IFN-a) in HDV (LOWR-2)

Who this might be right for
Chronic Hepatitis D Infection
Eiger BioPharmaceuticals 55
Large-scale testing (Phase 3)Not Yet RecruitingNCT07797231
What this trial is testing

Clinical Trial of TQA3605 Tablet in Combination With Nucleos(t)Ide Analogues(NAs) Versus NAs Alone for the Treatment of Patients With Chronic Hepatitis B Virus Infection Who Have Undergone Treatment and Exhibit Low Viral Load or Poor Response

Who this might be right for
Chronic Hepatitis B
Chia Tai Tianqing Pharmaceutical Group Co., Ltd. 930
Testing effectiveness (Phase 2)Study completedNCT02765802
What this trial is testing

Evaluate Pegylated Interferon Lambda Monotherapy in Patients With Chronic Hepatitis Delta Virus Infection

Who this might be right for
Hepatitis D, Chronic
EIT Pharma, Inc. 33
Large-scale testing (Phase 3)Ended earlyNCT03887702
What this trial is testing

Prophylactic Antiviral Therapy in Patients With Current or Past Hepatitis B Virus Infection Receiving Anti-Cancer Therapy for Solid Tumors

Who this might be right for
Hepatitis B InfectionMalignant Solid Neoplasm
SWOG Cancer Research Network 4
Not applicableStudy completedNCT00516945
What this trial is testing

Investigate Whether the Immediate Use or Deferred Use of an Anti-viral Drug Lamivudine Will Help to Better Safe-guard the Delivery of Chemotherapy in Patients With Cancer Who Are Also Hepatitis B Carriers

Who this might be right for
Hepatitis BNeoplasms
Hospital Authority, Hong Kong 110
Early research (Phase 1)Study completedNCT01336829
What this trial is testing

TMC125IFD1001 - Drug-Drug Interaction of Etravirine With Telaprevir and TMC278 With Telaprevir.

Who this might be right for
Hepatitis CHIV
Tibotec Pharmaceuticals, Ireland 33
Testing effectiveness (Phase 2)UnknownNCT04202653
What this trial is testing

Combination of ETV, TQ-A3334 and TQ-B2450 for CHB (Neptune Study)

Who this might be right for
Chronic Hepatitis b
Tongji Hospital 30
Testing effectiveness (Phase 2)Study completedNCT00987337
What this trial is testing

Filibuvir In Treatment Naive Hepatitis C Virus (HCV) Genotype 1 Subjects

Who this might be right for
HepatitisHepatitis C
Pfizer 288
Next Page